The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Application

23 Sep 2020 07:00

RNS Number : 7886Z
Tungsten Corporation PLC
23 September 2020
 

TUNGSTEN CORPORATION PLC

 

("Tungsten" or the "Company")

 

23 September 2020

 

Block Listing Application

 

Tungsten Corporation plc (AIM: TUNG) today announces that an application has been made to the London Stock Exchange for a block listing of 560,000 ordinary shares of 0.438 pence each in the Company (the "Ordinary Shares").

 

These Ordinary Shares will be issued from time to time in order to satisfy the requirement to allot shares under the Tungsten Corporation plc Deferred Share Bonus Plan ("the Plan").

 

It is expected that admission will become effective on 24 September 2020. The Ordinary Shares under the block listing will rank pari passu with the Company's existing Ordinary Shares.

 

Enquiries

Tungsten Corporation plc

Andrew Lemonofides, Chief Executive Officer 

+44 20 7280 6980

 

Canaccord Genuity Limited (Nominated Adviser and Broker)

Simon Bridges

Andrew Potts

 

+44 20 7523 8000

 

Tavistock Communications Financial PR & IR

Heather Armstrong

Jos Simson 

Katie Hopkins

+44 20 7920 3150

 

About Tungsten Corporation plc

 

Tungsten Corporation (AIM: TUNG) is the world's largest, compliant business transaction network. A leading global electronic invoicing and purchase order transactions network; Tungsten's mission is centred on enabling a touchless invoice process allowing businesses around the globe to gain maximum value from their invoice process.

 

Tungsten processes invoices for 74% of the FTSE 100 and 71% of the Fortune 500. It enables suppliers to submit tax compliant e-invoices in 50 countries, and last year processed transactions worth £195bn for organisations such as Caesars Entertainment, Computacenter, GlaxoSmithKline, Kraft Foods, Mohawk Industries, Mondelēz International, Procter & Gamble, Shaw Industries, Unilever and the US Federal Government.

 

Founded in 2000 and headquartered in London, Tungsten has offices in the US, Bulgaria and Malaysia, employing over 300 people.

 

For more information, please visit our website: https://www.tungsten-network.com/

 

Forward looking statements

This document contains forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Tungsten as of the date of this statement. All written or oral forward-looking statements attributable to Tungsten are qualified by this caution. Tungsten does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Tungsten's expectations

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSKKBBKOBKDNCB
Date   Source Headline
23rd Mar 20212:15 pmRNSCustomer Loss
17th Mar 20214:35 pmRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
12th Feb 20217:00 amEQSTungsten (TUNG): Foundations for growth in place
19th Jan 20214:15 pmRNSHolding(s) in Company
19th Jan 20214:10 pmRNSHolding(s) in Company
15th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 202111:00 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
18th Dec 20204:30 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSInterim Results
11th Dec 20207:00 amRNSNew Customer Win
10th Dec 20201:05 pmRNSHolding(s) in Company
1st Dec 20204:40 pmRNSSecond Price Monitoring Extn
1st Dec 20204:35 pmRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSTrading Update
2nd Nov 20204:31 pmRNSAdditional Listing and Total Voting Rights
2nd Nov 20204:30 pmRNSDirector/PDMR Shareholding
23rd Oct 20201:05 pmRNSHolding(s) in Company
20th Oct 20207:00 amRNSAppointment of Non-Executive Director
16th Oct 20203:50 pmRNSResult of AGM
15th Oct 20205:49 pmRNSAdditional Listing and TVR
2nd Oct 20207:00 amRNSAdditional Listing and Total Voting Rights
23rd Sep 20207:00 amRNSBlock Listing Application
15th Sep 202012:30 pmRNSHolding(s) in Company
11th Sep 20207:00 amRNSDirectorate Change
9th Sep 20207:00 amRNSHolding(s) in Company
7th Sep 20207:00 amRNSFinal Results
20th Jul 20207:00 amRNSTrading Update
2nd Jul 20201:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSReporting Timetable
17th Apr 20207:00 amRNSAppointment of Chief Financial Officer
3rd Apr 202012:05 pmRNSDirector/PDMR Share Dealing
2nd Apr 20202:15 pmRNSDirector/PDMR Share Dealing
31st Mar 20201:40 pmRNSAppointment of Non Executive Director
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 202011:16 amRNSChange of Nominated Adviser
23rd Mar 20207:00 amRNSCOVID-19 Update
19th Mar 202011:45 amRNSDirector/PDMR Share Dealing
16th Mar 20201:15 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSTrading Update for the Nine Months to 31 Jan 2020
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
5th Feb 20202:46 pmRNSDIRECTORATE CHANGE UPDATE
4th Feb 20204:40 pmRNSSecond Price Monitoring Extn
4th Feb 20204:35 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSDIRECTORATE CHANGE
10th Jan 20204:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.